Answer
Leqvio (inclisiran sodium) has not been studied in patients with severe hepatic impairment (Child-Pugh class C).
Sources for this answer
- Leqvio 284 mg solution for injection in pre filled syringeNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 4Document updated
Sources checked